Online citations, reference lists, and bibliographies.

Seventh Report Of The Joint National Committee On Prevention, Detection, Evaluation, And Treatment Of High Blood Pressure.

Aram V. Chobanian, George L Bakris, Henry R. Black, William C. Cushman, Lee A. Green, Joseph L Izzo, Daniel W Jones, Barry J. Materson, Suzanne Oparil, Jackson T. Wright, Edward J. Roccella
Published 2003 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
The National High Blood Pressure Education Program presents the complete Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Like its predecessors, the purpose is to provide an evidence-based approach to the prevention and management of hypertension. The key messages of this report are these: in those older than age 50, systolic blood pressure (BP) of greater than 140 mm Hg is a more important cardiovascular disease (CVD) risk factor than diastolic BP; beginning at 115/75 mm Hg, CVD risk doubles for each increment of 20/10 mm Hg; those who are normotensive at 55 years of age will have a 90% lifetime risk of developing hypertension; prehypertensive individuals (systolic BP 120-139 mm Hg or diastolic BP 80-89 mm Hg) require health-promoting lifestyle modifications to prevent the progressive rise in blood pressure and CVD; for uncomplicated hypertension, thiazide diuretic should be used in drug treatment for most, either alone or combined with drugs from other classes; this report delineates specific high-risk conditions that are compelling indications for the use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, calcium channel blockers); two or more antihypertensive medications will be required to achieve goal BP (<140/90 mm Hg, or <130/80 mm Hg) for patients with diabetes and chronic kidney disease; for patients whose BP is more than 20 mm Hg above the systolic BP goal or more than 10 mm Hg above the diastolic BP goal, initiation of therapy using two agents, one of which usually will be a thiazide diuretic, should be considered; regardless of therapy or care, hypertension will be controlled only if patients are motivated to stay on their treatment plan. Positive experiences, trust in the clinician, and empathy improve patient motivation and satisfaction. This report serves as a guide, and the committee continues to recognize that the responsible physician's judgment remains paramount.
This paper references
10.1001/archinte.1988.00380060036009
Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension.
Vasilios Papademetriou (1988)
American College of Physicians-American Society of Internal Medicine; American College of Preventive Medicine
[Hypertension in women].
Kazuhiko Kushima (1966)
10.4065/75.10.1105
Hypertension: A Companion to Brenner and Rector's The Kidney
John William Graves (2000)
– COMPLETE REPORT
Chobanian (1249)
Department of Health and Human Services, National Heart, Lung, and Blood Institute. National High Blood Pressure Education Program. Available at
(2003)
10.1001/jama.288.15.1882
Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program.
Paul Kieran Whelton (2002)
10.1001/jama.290.2.199
Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000
Ihab Hajjar (2003)
Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community- Based Study
Keith Clark (2000)
10.1093/aje/kwf145
Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.
David E. Laaksonen (2002)
10.1161/01.STR.19.7.820
A prospective study of cerebral artery atherosclerosis.
Dwayne M. Reed (1988)
Are we losing the game? Cardiovascular health in minority children.
Samuel S. Gidding (2002)
1999 Clinical Advisory Treatment of Hypertension and Diabetes.
James R Sowers (2000)
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
(2002)
10.1111/j.1527-5299.2002.00752.x
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
David E. Tepper (2002)
10.1016/S0140-6736(05)61724-2
Effect of renal-artery stenting on progression of renovascular renal failure
George Geroulakos (1997)
American Academy of Ophthalmology. Basic and Clinical Science Course American Academy of Ophthalmology
(1999)
10.1136/bmj.317.7160.703
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
M R Stearne (1998)
10.1056/NEJMoa022273
Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.
Denis L. Clement (2003)
10.1001/jama.288.23.2981
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Curt D. Furberg (2002)
10.1161/01.HYP.37.1.12
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial
Henry R. Black (2001)
10.1016/j.accreview.2003.08.045
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.
Ihab Hajjar (2003)
10.1164/ajrccm.165.5.2104087
Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.
Naresh M. Punjabi (2002)
10.1001/archinte.161.13.1581
Impact of overweight on the risk of developing common chronic diseases during a 10-year period.
Alison E Field (2001)
10.1001/jama.286.4.421
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
Hertzel C. Gerstein (2001)
10.1161/01.STR.27.3.401
Investigating the relationship between stroke and obstructive sleep apnea.
Mark Eric Dyken (1996)
Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation
AS Shamsuzzaman (2002)
Treatment of hypertensive emergencies and urgencies Hypertension Primer: The Essentials of High Blood Pressure: Basic Science, Population Science, and Clinical Management
Dg Vidt (2003)
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women
Grimm Rh Jr (1997)
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Jaakko Tuomilehto (1999)
10.1001/jama.279.22.1813
Why are physicians not prescribing diuretics more frequently in the management of hypertension?
Marvin Moser (1998)
MD (Mayo Clinic and Mayo Medical School
Jack P Whisnant
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Jan A Staessen (1997)
of Health and Human Services
U S Departmen (1996)
10.1097/00132586-200208000-00043
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
Richard A. Wiklund (2002)
10.1046/j.1523-1755.2002.00629.x
Impact of renal failure on the risk of myocardial infarction and death.
Srinivasan Beddhu (2002)
10.1161/01.STR.22.8.993
An autopsy study of the incidence of lacunes in relation to age, hypertension, and arteriosclerosis.
Koichiro Dozono (1991)
Interpretation and evaluation of clinical guidelines
E Roccella (2003)
10.1007/BF03307079
The Treatment of Hypertensive Emergencies and Urgencies
Norman M. Kaplan (1992)
[Primary aldosteronism].
K. Hatteland (1969)
10.1161/CIRCULATIONAHA.105.539528
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
Peter W. F. Wilson (2005)
10.1161/01.HYP.25.3.305
Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.
Vicki L. Burt (1995)
10.1097/00126097-199900460-00011
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Jan A Staessen (1999)
10.1161/01.CIR.83.1.356
An updated coronary risk profile. A statement for health professionals.
Karla M. Anderson (1991)
The Münster Heart Study (PROCAM). Results of follow-up at 8 years.
Gerd Assmann (1998)
10.1161/01.str.32.1.280
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.
Larry B Goldstein (2001)
10.1016/S0140-6736(00)03307-9
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
Bruce Neal (2000)
Measuring your blood pressure
World Hypertension League (2003)
10.1001/archinte.1978.03630330009005
Hypertension and transplantation.
Phillip Hall (1978)
PAC (American Academy of Physician Assistants
John J Davis
Association and linkage analysis of the alpha-adducin gene and blood pressure.
Molly S. Bray (2000)
10.1136/jnnp.72.6.737
Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects
Hironobu Koga (2002)
10.1016/S0895-7061(99)00241-1
Statement from the National High Blood Pressure Education Program: prevalence of hypertension.
M M Wolz (2000)
10.1164/ajrccm.163.2.2005037
Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome.
Jacqueline F. Faccenda (2001)
10.7326/0003-4819-130-6-199903160-00002
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
Andrew S. Levey (1999)
10.1001/archinte.159.10.1104
Clustering of metabolic factors and coronary heart disease.
Peter W.F. Wilson (1999)
10.7326/0003-4819-126-10-199705150-00002
Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men
François Gueyffier (1997)
10.1056/NEJMoa011303
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
Edmund J. Lewis (2001)
10.1161/01.HYP.35.2.539
Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification.
Lorraine G. Ogden (2000)
10.1056/NEJM199903043400902
Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension
Jaakko Tuomilehto (1999)
10.1161/01.CIR.0000018948.95175.03
Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea
Abu S. M. Shamsuzzaman (2002)
Persons 65 Years Old and Over–Characteristics by Sex: 1980 to 2000
U S. Census Bureau (2001)
10.1016/S0009-9236(96)90155-1
Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects.
William J. Elliott (1996)
, microalbuminuria , and risk of ischemic heart disease
HC Gerstein (2000)
10.1016/S0002-8703(03)00227-8
Metabolic syndrome and coronary angiographic disease progression: the Women's Angiographic Vitamin & Estrogen trial.
Judith Hsia (2003)
10.1111/j.1524-6175.2005.04087.x
Gender and blood pressure.
Suzanne Oparil (2005)
10.1001/archinte.159.10.1033
Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy.
Timothy Charles Fagan (1999)
10.1212/WNL.53.1.132
MRI white matter hyperintensities
Reinhold Schmidt (1999)
Inadequate management of blood pressure in a hypertensive population.
Harry J. Ward (1999)
10.7326/0003-4819-139-4-200308190-00006
Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis
Tazeen Hasan Jafar (2003)
10.1056/NEJM200003303421301
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.
Todd W. Gress (2000)
10.1056/NEJM199311113292004
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
Edmund J. Lewis (1993)
Becoming an information master: a guidebook to the medical information jungle.
Allen F. Shaughnessy (1994)
10.1161/01.HYP.35.4.858
National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence.
Aram V. Chobanian (2000)
10.1038/sj.jhh.1000476
Conventional and ambulatory blood pressure and menopause in a prospective population study
Ja Staessen (1997)
The hypertension detection and follow-up program.
Langford Hg (1984)
10.1097/00004872-199506000-00006
Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass
Giuseppe Licata (1995)
10.1001/jama.289.8.1027
Measuring blood pressure accurately: new and persistent challenges.
Daniel W Jones (2003)
10.1097/00008483-200007000-00013
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Jiang He (1999)
10.1016/S0735-1097(02)02663-3
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.
Guruprasad Manjunath (2003)
10.1161/01.STR.0000064841.47697.22
Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association
Harold P. Jr Adams (2003)
10.1161/01.CIR.0000072346.56728.E4
Sleep‐Disordered Breathing and Cardiovascular Disease
Robert L. Wolk (2003)
10.1016/S0002-9149(02)02661-9
Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.
Andrew A Whelton (2002)
10.1016/s0095-5108(18)30498-6
Chronic hypertension in pregnancy.
Jeffrey C. Livingston (2001)
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.
Frank M. Sacks (2001)
10.1001/archinte.162.14.1636
Successful blood pressure control in the African American Study of Kidney Disease and Hypertension.
Jackson T. Wright (2002)
10.1056/NEJM200003233421202
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
Paul M. Ridker (2000)
including the results of the OCTAVE study. FDA, Center for Drug Evaluation and Research, Division of Cardio-Renal Drug Products
J Lawrence
10.1056/NEJM199909023411001
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
Bertram Pitt (1999)
PR
10.1016/S0749-3797(01)00356-7
An evidence-based review of patient-centered behavioral interventions for hypertension.
L. Ebony Boulware (2001)
10.1016/S0002-9343(99)00113-8
Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications.
Andrew A Whelton (1999)
10.1161/01.CIR.97.21.2154
Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations.
Shahrokh Javaheri (1998)
10.1161/01.CIR.93.1.4
Compliance enhancement. A call for multidisciplinary team approaches.
Martha N. Hill (1996)
Blood Pressure Monitoring. Task force V: White-coat hypertension.
Thomas G. Pickering (1999)
10.1177/089198879901200102
Systolic Blood Pressure within an Intermediate Range May Reduce Memory Loss in an Elderly Hypertensive Cohort
Ned Sacktor (1999)
10.1001/archneur.1995.00540340067014
White matter lesions and disequilibrium in older people. II. Clinicopathologic correlation.
Robert W. Baloh (1995)
10.1056/NEJMoa020265
Long-term trends in the incidence of and survival with heart failure.
Daniel Levy (2002)
Treatment of pregnant hypertensive patients
SJ Taler (2003)
National Institutes of Health, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program. National High Blood Pressure Education Month
Sleep apnea and heart failure, part I: obstructive sleep apnea. Circulation
TD Bradley (2003)
10.1161/01.HYP.15.4.348
Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study.
Barry J. Materson (1990)
Effects of intensive bloodpressure lowering and low - dose aspirin in patients with hypertension : principal results of the Hypertension Optimal Treatment ( HOT ) randomised trial . HOT Study Group
L Hansson (2003)
10.1161/01.HYP.35.3.844
Prognostic value of ambulatory blood pressure : current evidence and clinical implications.
Paolo Verdecchia (2000)
10.1161/01.HYP.35.5.1025
Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.
L V Franse (2000)
10.1056/NEJM200105313442201
Effect of carvedilol on survival in severe chronic heart failure.
Milton Packer (2001)
10.1212/WNL.51.4.986
Association of midlife blood pressure to late-life cognitive decline and brain morphology
Gary E. Swan (1998)
10.1046/j.1523-1755.2002.00213.x
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
Robert Schrier (2002)
Clinical practice. Nephropathy in patients with type 2 diabetes.
Giuseppe Remuzzi (2002)
10.1001/jama.288.21.2709
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
Hanna-Maaria Lakka (2002)
10.1016/S0140-6736(99)07330-4
Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials
Jan A Staessen (2000)
10.1097/00008483-199205000-00014
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
(1991)
10.1016/S0749-3797(03)00025-4
Standardized health plan reporting in four areas of preventive health care.
Sarah Shih (2003)
10.1161/01.HYP.35.2.544
Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.
Jiang He (2000)
Hypertension and its treatment in postmenopausal women: baseline data from the Women’s Health Initiative. Hypertension
S Wassertheil-Smoller (2000)
Orthostatic hypotension.
R C Ziss (1957)
10.4135/9781412963848.n252
Social Learning Theory
Albert Bandura (1971)
10.1161/01.STR.22.4.442
Medullary arteries in aging and dementia.
Akihiro Furuta (1991)
Heart disease and stroke statistics–2003 update
(2002)
10.1161/01.HYP.17.1_Suppl.I16
Implications of the INTERSALT Study
Rose Stamler (1991)
10.1161/01.CIR.0000031732.78052.81
Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population
Hans L. Hillege (2002)
10.7326/0003-4819-121-4-199408150-00011
Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis
Anthony G. Johnson (1994)
10.1016/S0735-1097(02)02848-6
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).
Raymond J. Gibbons (2003)
10.1016/S0140-6736(01)06710-1
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study
Ramachandran S Vasan (2001)
10.1001/jama.283.14.1829
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study.
F. Javier Nieto (2000)
10.1016/S0002-9343(96)00265-3
The impact of ethnicity on response to antihypertensive therapy.
Kenneth A. Jamerson (1996)
10.1001/jama.1997.03550030052033
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension
John B. Kostis (1997)
10.1056/nejm199810293391821
THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION
AYMOND (2000)
10.1161/01.CIR.90.2.878
Reduced Heart Rate Variability and Mortalit Risk in an Elderly Cohort: The Framingham Heart Study
Hiroharu Tsuji (1994)
10.1161/01.CIR.0000061757.12581.15
Sleep Apnea and Heart Failure: Part I: Obstructive Sleep Apnea
T. Douglas Bradley (2003)
10.1210/jcem.85.3.6484
Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia.
Alexandros N. Vgontzas (2000)
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.
Tazeen Hasan Jafar (2001)
10.1136/bmj.314.7085.947
Obtaining useful information from expert based sources
David C. Slawson (1997)
10.1016/S0140-6736(99)01376-8
Impact of sleep debt on metabolic and endocrine function
Karine Spiegel (1999)
10.1161/01.HYP.0000042097.39655.B7
Treatment of cardiovascular and renal risk factors in the diabetic hypertensive.
James R Sowers (2002)
DPM (American Podiatric Medical Association
Pamela J Colman
update of the working group reports on chronic renal failure and reno - vascular hypertension
RP Lifton
Data tables: results from USDA's 1994 continuing survey of food intakes by individuals and 1994 diet and health knowledge survey
Le Cleveland (1996)
MD (University of Texas Southwestern Medical School at Dallas
Mary M Hand
Effect of captopril on mortality and morbidity in patients with left Survival and Ventricular Enlargement trial. The SAVE Investigators
Ma Pfeffer
10.1097/00006250-200303000-00030
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events*
Aul (2002)
10.1001/jama.1997.03540330061036
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.
Bruce M. Psaty (1997)
10.1161/01.CIR.98.21.2290
Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program.
Kamal H. Masaki (1998)
10.1001/jama.1982.03320370021023
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
(1982)
10.1016/S0140-6736(87)90127-9
THE DOMINANCE OF SALT IN MANUFACTURED FOOD IN THE SODIUM INTAKE OF AFFLUENT SOCIETIES
WilliamH. James (1987)
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
Sc Prospective (2002)
10.1001/jama.282.6.539
Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension
Jan A Staessen (1999)
10.1016/S0895-7061(00)01214-0
Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study.
Roberto Fogari (2001)
10.1093/aje/kwf114
Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study.
J Stevens (2002)
10.1056/NEJM197308302890913
The therapeutic challenge of systolic hypertension.
J Koch-weser (1973)
10.1001/archinte.1995.00430100105012
Long-term effects of antihypertensive agents on proteinuria and renal function.
Daniel D. Maki (1995)
10.1007/s11892-003-0058-1
Association of albuminuria and the metabolic syndrome
Kevin Rowley (2003)
10.1038/ki.1998.37
Revascularization in atherosclerotic renal artery disease.
Stephen C. Textor (1998)
Hypertension and other cardiovascular disease risk factors among Mexican Americans, Cuban Americans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey.
Carlos J. Crespo (1996)
Diabetes and cardiovascular disease: a statement for healthcare professionals from the
Sm Grundy (1999)
Prognostic value of ambulatory blood-pressure 1244 Hypertension December 2003 by gest on July 9, 2017 http://hyhajournals.org/ D ow nladed from recordings in patients with treated hypertension
DL Clement (2003)
Prognostic value of ambulatory blood-pressure 1244 Hypertension December 2003 by gest on Jauary 9, 2018 http://hyhajournals.org/ D ow nladed from recordings in patients with treated hypertension
DL Clement (2003)
10.1212/WNL.56.7.921
Longitudinal study of blood pressure and white matter hyperintensities
Carole Dufouil (2001)
10.1016/S0003-0465(16)32942-1
The national high blood pressure education program.
John b. Stokes (1974)
10.1001/jama.286.22.2845
Epidemic increase in childhood overweight, 1986-1998.
Richard säv. Strauss (2001)
Association between the alpha-adducin Gly460Trp polymorphism and systolic blood pressure in familial combined hyperlipidemia.
Esther Beeks (2001)
Cardiovascular disease enhanced dissemination and utilization centers (EDUCs) awardees
National Heart (2003)
10.1016/S0002-9343(96)00267-7
The evolution of low-dose diuretic therapy: the lessons from clinical trials.
Henry R. Black (1996)
10.1016/S0895-7061(97)00211-2
Hypertension in blacks.
Richard S. Cooper (1997)
US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion
U S Department Of Health (1995)
Hypertension Primer: The Essentials of High Blood Pressure
Joseph L Izzo (1993)
[Sleep apnea and cardiovascular disease].
K. Narkiewicz (2002)
J Clin Hypertens
(1986)
Treatment of hypertensive patients with peripheral arterial disease Hypertension Primer: The Essentials of High Blood Pressure: Basic Science, Population Science, and Clinical Management
Jw Olin (2003)
10.1001/archinte.1990.00040031707020
A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.
Elijah Saunders (1990)
10.1056/NEJMoa030808
Estrogen plus progestin and the risk of coronary heart disease.
Joann E. Manson (2003)
10.1097/00126097-200212000-00004
Limitations of current validation protocols for home blood pressure monitors for individual patients
William Gerin (2002)
10.1007/s11906-003-0028-7
Insulin resistance and the sympathetic nervous system
Brent M. Egan (2003)
10.1046/j.1464-410x.2000.00938.x
Atlas of Diseases of the Kidney
Patrick Whelan (2001)
10.1053/ajkd.2000.16225
Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.
George L Bakris (2000)
10.1016/0002-8703(93)90128-V
Influence of heart rate on mortality among persons with hypertension: the Framingham Study.
Matthew W Gillman (1993)
10.1016/S1053-2498(01)00776-8
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.
Sharon Ann Hunt (2002)
10.1136/bmj.294.6585.1443
Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
H. H. Parving (1987)
10.1001/archinte.151.9.1769
Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials.
Kenneth L. Radack (1991)
10.1378/chest.107.2.362
Body fat distribution and sleep apnea severity in women.
Richard P. Millman (1995)
10.1016/S0140-6736(02)08090-X
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Lars Lindholm (2002)
A randomized trial of betablockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS)
(1994)
National Institutes of Health, National Heart, Lung, and Blood Institute. NHLBI Healthy People
(2003)
http://www.nhlbi.nih.gov/about/nhbpep/nhbp_abs.htm 41 Available at: http:// www.healthypeople.gov/. Accessed November, 2003. 42. US Department of Health and Human Services
(2002)
Ann Arbor, Mich)
Pac Davis
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. For the LIFE Study Investigators
Pm Okin (2002)
Pathophysiology of sleep apnea Hypertension Primer: The Essentials of High Blood Pressure: Basic Science, Population Science, and Clinical Management
Bj Morgan (2003)
10.1093/ndt/13.3.564
Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
Roland E Schmieder (1998)
Pseudohypertension: a diagnostic dilemma.
James R. Oster (1986)
Physician Role in Lack of Awareness and Control of Hypertension.
David J. Hyman (2000)
10.2337/diacare.23.9.1278
Diabetes trends in the U.S.: 1990-1998.
Ali H. Mokdad (2000)
of Health and Human Services, National Heart, Lung, and Blood Institute
U. S. Departmen (2003)
10.1097/00132586-200006000-00059
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Bertram Pitt (2000)
Prevalence and trends in obesity
KM Flegal (1999)
10.7326/0003-4819-134-8-200104170-00007
Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial
Johannes F. E. Mann (2001)
PROSPECTIVE STUDY OF THE ASSOCIATION BETWEEN SLEEP-DISORDERED BREATHING AND HYPERTENSION
Aul (2000)
10.2307/30145579
American Hospital Association
Robert A. Weinstein (1994)
10.1001/jama.288.19.2421
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
Jackson T. Wright (2002)
10.1016/S0140-6736(99)12323-7
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy
Heart Outcomes Prevention Evaluation Study Investigators (2000)
10.1016/S0735-1097(01)01567-4
Heart failure with preserved systolic function. A different natural history?
Michele Senni (2001)
10.1016/S0002-9343(96)00268-9
Evidence for the efficacy of low-dose diuretic monotherapy.
John M. Flack (1996)
Cognitive decline associated with worsening of white matter lesions: a 6-year follow-up study
S Yamaguchi (1996)
Treatment of hypertensive patients with peripheral arterial disease
JW Olin (2003)
10.1002/j.1552-4604.1995.tb04116.x
Management of hypertensive urgencies and emergencies.
Walid Abdelwahab (1995)
Prognostic value of ambulatory blood-pressure 1244 Hypertension December 2003 recordings in patients with treated hypertension
DL Clement (2003)
The heart truth: a national awareness campaign for women about heart disease
US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute. Facts about the DASH eating plan
(2002)
10.1056/NEJMoa011161
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
Barry M. Brenner (2001)
10.1056/nejm199401133300225
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
Agnès Fournier (1994)
10.1001/jama.278.3.212
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
John B. Kostis (1997)
10.1191/1358863x02vm412ra
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Jay P Garg (2002)
10.1016/S0140-6736(98)05012-0
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
Lennart Hansson (1999)
10.1056/NEJM199512213332503
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Lars Køber (1995)
10.1056/NEJM199611283352203
Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.
Robert G Nelson (1996)
10.1056/NEJM199612053352301
Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.
Dennis Thomas Mangano (1996)
10.1016/S0092-8674(01)00241-0
Molecular Mechanisms of Human Hypertension
Richard P. Lifton (2001)
10.1001/archinte.163.9.1069
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Christophe Tzourio (2003)
10.1056/NEJM199607253350407
Treatment of hypertension in pregnant women.
Baha M. Sibai (1996)
10.1016/S0140-6736(01)06226-2
Blood-pressure lowering for the secondary prevention of stroke
Jan A Staessen (2001)
Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials
SP Whelton (2002)
Persons 65 Years Old and Over-Characteristics by Sex
U S Census Bureau (1980)
Treatment of hypertension patients with ischemic heart disease
C. Rosendorff (2003)
Epidemic increase in childhood overweight
Rs Strauss (1986)
The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure
(1997)
Prognostic value of ambulatory blood-pressure 1244 Hypertension December 2003 by gest on M ay 5, 2017 http://hyhajournals.org/ D ow nladed from recordings in patients with treated hypertension
DL Clement (2003)
Obstructive sleep apnea and the recurrence of atrial fibrillation Investigating the relationship between stroke and obstructive sleep apnea
R Kanagala (1996)
10.1001/archinte.1990.00390190152026
Hypotensive responses to common daily activities in institutionalized elderly. A potential risk for recurrent falls.
Palmi V. Jonsson (1990)
10.1067/mob.2000.107928
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.
(2000)
10.1001/archopht.116.3.297
United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.
Eva M. Kohner (1998)
10.1016/S0140-6736(02)08089-3
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Björn Dahlöf (2002)
10.1161/01.RES.85.8.753
Oxidative stress as a regulator of gene expression in the vasculature.
Charles A. Kunsch (1999)
Market Driven Health Care: Who Wins, Who Loses In The Transformation Of America's Largest Service Industry
Regina Herzlinger (1996)
10.1148/radiology.167.2.3357964
Deep white matter infarction: correlation of MR imaging and histopathologic findings.
Valin G. Marshall (1988)
10.1016/S0749-3797(00)00254-3
Motivational interviewing in health care settings. Opportunities and limitations.
Karen M. Emmons (2001)
10.1161/01.HYP.35.3.838
Progressive resistance exercise and resting blood pressure : A meta-analysis of randomized controlled trials.
G. A. Kelley (2000)
10.1161/01.HYP.0000090122.38230.41
Hypertensive Retinal Vessel Wall Signs in a General Older Population: The Blue Mountains Eye Study
Jie Jin Wang (2003)
10.1136/bmj.303.6810.1100
beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination.
Sunithi Solomon (1991)
10.1001/archinte.160.3.301
Improving preventive care by prompting physicians.
E. Andrew Balas (2000)
10.1016/S0735-1097(99)00407-6
Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment.
Nathan Peled (1999)
10.1056/NEJMoa022479
Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea.
Yasuyuki Kaneko (2003)
10.1161/01.HYP.36.4.594
Differential Control of Systolic and Diastolic Blood Pressure: Factors Associated With Lack of Blood Pressure Control in the Community
Donald Lloyd-Jones (2000)
10.1056/NEJM199108013250501
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
Salim Yusuf (1991)
10.1111/j.1524-6175.2002.02045.x
Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
William C. Cushman (2002)
10.1001/archinte.160.6.825
Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
William C. Cushman (2000)
10.1161/01.HYP.35.5.1021
Clinical Advisory Statement. Importance of systolic blood pressure in older Americans.
Joseph L Izzo (2000)
10.1001/archneur.58.12.1985
Current concepts in mild cognitive impairment.
Ronald C. Petersen (2001)
10.1016/S0749-3797(02)00580-9
Counseling to promote a healthy diet in adults: a summary of the evidence for the U.S. Preventive Services Task Force.
Michael P Pignone (2003)
Ethnic differences in systolic blood pressure control in hypertensive patients with coronary artery disease
RM Cooper-DeHoff (2003)
MD (National Institutes of Diabetes and Digestive and Kidney Diseases
H Thomas
MD (Cleveland Clinic Foundation
Donald G Vidt
10.1097/00004872-199005000-00006
Pseudohypertension in the elderly.
Iwao Kuwajima (1990)
Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension
J He (2000)
RA 111. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
(2000)
Health Resources and Services Administration; National Center for Health Statistics; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases
MD (Veterans Affairs Medical Center
C William
10.1056/NEJMoa012512
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler (2002)
10.1161/01.HYP.27.1.144
Hypertensive urgencies and emergencies. Prevalence and clinical presentation.
B Zampaglione (1996)
10.1001/archneur.1991.00530180087022
Sclerosing vasculopathy of the central nervous system in nonelderly demented patients.
Melinda L. Estes (1991)
of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute
US Departmen (2003)
Hypertensive crisis. In: Oparil S, Weber MA (eds): Hypertension: A Companion to Brenner and Recot’s The Kidney
DA Calhoun (2000)
10.1016/S1388-9842(03)00052-7
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme.
John J V McMurray (2003)
Sleep-disordered breathing and cardiovascular disease: crosssectional results of the Sleep Heart Health Study
E Shahar (2001)
Strong Heart Study Data Book: A Report to American Indians Communities. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute
National Heart (2001)
clinical advisory: treatment of hypertension and diabetes
JR Sowers (1999)
10.1001/archinte.1997.00440420033005
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.
Black Hr (1997)
10.1016/S0140-6736(98)04311-6
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
Lennart Hansson (1998)
10.1016/S0140-6736(98)08127-6
Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials
François Gueyffier (1999)
10.1001/archinte.162.20.2325
Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study.
Bruce M. Psaty (2002)
10.1001/archinte.161.9.1207
Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).
Josef Coresh (2001)
10.1161/01.CIR.88.5.2460
Human blood pressure determination by sphygmomanometry.
Dorothee Perloff (1993)
10.1161/hy1101.093424
Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Xue Xin (2001)
10.1097/00000539-200205000-00002
ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluati
Kim A. Eagle (2002)
10.1161/01.CIR.103.9.1245
Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?: The Framingham Heart Study
Stanley S. Franklin (2001)
10.1161/01.STR.24.6.779
Pattern of Cerebral Atherosclerosis in Hong Kong Chinese: Severity in Intracranial and Extracranial Vessels
Suet Yi Leung (1993)
10.1016/S1062-1458(02)00780-8
Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension.
Bruce M. Psaty (2002)
10.1001/archneur.1992.00530310095018
Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging.
Marc I. Chimowitz (1992)
10.1016/S0895-7061(00)01177-8
Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group.
Robert A. Kloner (2001)
10.1007/s11906-999-0044-3
Reflections on the sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure
Sheldon G. Sheps (1999)
10.1016/S0891-5849(00)00438-X
Hyperinsulinemia: the missing link among oxidative stress and age-related diseases?
Francesco S. Facchini (2000)
10.1001/archinte.161.5.729
Are aneroid sphygmomanometers accurate in hospital and clinic settings?
Vincent J. Canzanello (2001)
[Management of hypertensive patients with left ventricular hypertrophy].
E. Ambrosioni (2002)
DO (Philadelphia College of Osteopathic Medicine
William A Nickey
Arterial
JS Jensen (1999)
Measuring your blood pressure Available at
Hypertension World (2003)
Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
M Raj Lakshman (1999)
10.1001/archinte.1996.00440040047006
Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study.
C Elizabeth Lewis (1996)
10.1016/S0140-6736(98)03086-4
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
on behalf of the Syst-Eur Investigators (1998)
10.1161/01.HYP.35.5.1173
Effects of sleep deprivation on neural circulatory control.
Masahiko Kato (2000)
National High Blood Pressure Education Program.
Claude Lenfant (1986)
10.1097/00008483-200105000-00012
EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET
Rank (2000)
10.1001/jama.289.14.1799
Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.
Katherine Esposito (2003)
10.1161/01.CIR.100.10.1134
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
Scott M Grundy (1999)
10.1056/NEJM199209033271001
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
Marc Pfeffer (1992)
10.1006/pmed.2000.0733
Characteristics of inactive primary care patients: baseline data from the activity counseling trial. For the Activity Counseling Trial Research Group.
Denise G. Simons-Morton (2000)
10.1056/NEJM199304293281704
The occurrence of sleep-disordered breathing among middle-aged adults.
Terry B Young (1993)
Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-tomoderate hypertensive patients
MH Weinberger (1985)
American Osteopathic Association
Salud para su Corazón (For the Health of Your Heart)
National Heart
Physical activity and coronary heart disease in women: is “no pain, no gain
IM Lee (2001)
Strong Heart Study Data Book: A Report to American Indians Communities. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute. NIH Publication No. 01-3285
R Cooper (1997)
RPh, DDS (Health Resources and Services Administration
David B Snyder
10.1053/j.ajkd.2004.10.009
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.
Allan J. Collins (2003)
10.1056/nejm199012133232413
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.
Dante E. Manyari (1990)
Sleep apnea and heart failure, part I: obstructive sleep apnea The association of hypertension and secondary cardiovascular disease with sleepdisordered breathing
Td Bradley (2003)
10.1001/jama.281.5.438
Current and remote blood pressure and cognitive decline.
Robert J Glynn (1999)
10.1161/01.HYP.35.4.898
Arterial hypertension, microalbuminuria, and risk of ischemic heart disease.
Jan Skov Jensen (2000)
10.1001/archopht.1996.01100140706012
The American Academy of Ophthalmology.
Charles E. Letocha (1996)
10.1056/NEJM199304013281303
Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Barry J. Materson (1993)
10.1016/S0140-6736(02)11911-8
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
Prospective Studies Collaboration (2002)
10.1161/01.CIR.81.2.602
Benefit of exercise conditioning for patients with peripheral arterial disease.
William R Hiatt (1990)
10.1016/S0140-6736(99)10327-1
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
Lennart Hansson (1999)
10.1161/01.HYP.26.1.60
Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.
Vicki L. Burt (1995)
10.2337/diacare.21.1.s23
Standards of Medical Care for Patients With Diabetes Mellitus
(1998)
10.1161/01.HYP.0000014323.99765.16
Effects of Celecoxib on Ambulatory Blood Pressure in Hypertensive Patients on ACE Inhibitors
William B White (2002)
10.7326/0003-4819-139-3-200308050-00005
Sexual Function in Men Older Than 50 Years of Age: Results from the Health Professionals Follow-up Study
Constance G Bacon (2003)
10.1001/archinte.163.4.427
The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.
Yongwoo Park (2003)
10.1001/jama.289.18.2379
Relationship of changes in physical activity and mortality among older women.
Edward W. Gregg (2003)
10.1152/physrev.1995.75.3.473
Pathophysiology of insulin resistance in human disease.
Gerald M. Reaven (1995)
10.1056/nejm199702203360801
The effect of digoxin on mortality and morbidity in patients with heart failure.
Gilbert J. Perry (1997)
Renal artery angioplasty: technical results and clinical outcome in 320 patients.
Stanford M. Goldman (1996)
Frontiers in congestive heart failure: Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
David E. Tepper (1999)
RA 145. The Capricorn Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAP- RICORN randomised trial
(1992)
10.1001/archinte.159.10.1097
Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
Timothy M E Davis (1999)
10.1378/chest.123.1.244
The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing.
Richard A. Dart (2003)
10.1056/NEJM200003303421310
Antihypertensive therapy and the risk of type 2 diabetes mellitus.
James R Sowers (2000)
PR 89. National Kidney Foundation Guideline. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative
(2002)
Magnetic resonance imaging cerebral abnormalities and neuropsychologic test performance in elderly hypertensive subjects: a casecontrol study
R Schmidt (1995)
Management of sleep apnea.
Neal Clemenson (2002)
Ill); Vicki Burt, ScM, RN (National Center for Health Statistics
Chicago Center
10.1016/S0140-6736(95)91747-0
Prevention of diabetic renal disease with special reference to microalbuminuria
Carl Erik Mogensen (1995)
10.1001/jama.288.14.1723
Prevalence and trends in obesity among US adults, 1999-2000.
Katherine M. Flegal (2002)
Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
Stephen MacMahon (2001)
10.1001/archinte.158.15.1681
Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.
Jan A Staessen (1998)
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
Michele Bortolini (2003)
10.1016/S0140-6736(00)02527-7
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
Morris Jonathan Brown (2000)
10.7326/0003-4819-137-6-200209170-00025
Clinical inertia.
James L. Wofford (2002)
10.1016/S0895-7061(02)02945-X
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
Peter M. Okin (2002)
Effects of sleep deprivation on neural circulatory control. Hypertension
M Kato (2000)
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke
(1995)
Understanding and improving health and objectives for improving health. Healthy People
U S Department Of Health (2000)
Blood pressure and coronary heart disease.
Anders Himmelmann (1999)
10.1161/01.CIR.95.8.2007
Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
John S. Gottdiener (1997)
10.1007/s11883-000-0111-3
Lifestyle factors and stroke risk: Exercise, alcohol, diet, obesity, smoking, drug use, and stress
Bernadette Boden-Albala (2000)
10.1097/00004872-199608000-00001
The 1996 report of a World Health Organization expert committee on hypertension control.
J W Chalmers (1996)
10.1038/sj.jhh.1001580
Sexual activity in hypertensive men
Andrea Della Chiesa (2003)
10.1016/s0735-1097(03)82497-x
Rofecoxib, but not celecoxib or naproxen, increases mean 24-hour systolic blood pressure in treated hypertensive patients with osteoarthritis and type 2 diabetes mellitus
James R Sowers (2003)
Prevalence and trends in obesity among US adults
K M Flegal (1999)
10.1016/S0140-6736(87)92441-X
PLACEBO-CONTROLLED COMPARISON OF CAPTOPRIL, ATENOLOL, LABETALOL, AND PINDOLOL IN HYPERTENSION COMPLICATED BY INTERMITTENT CLAUDICATION
DavidH. Roberts (1987)
Gender and blood pressure Hypertension Primer: The Essentials of High Blood Pressure: Basic Science, Population Science, and Clinical Management
Da Calhoun (2003)
Trends in prevalence, awareness, treatment, and control of hypertension in the United States Reducing risks, promoting healthy life
I Hajjar (1988)
10.1001/jama.289.16.2083
Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.
Lawrence J. Appel (2003)
10.1016/0895-7061(96)82092-9
Sympathetic neural mechanisms in obstructive sleep apnea.
V. K. Somers (1995)
10.2337/diacare.25.9.1612
Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome.
David E. Laaksonen (2002)
10.1161/01.HYP.13.5_Suppl.I36
Controlled Clinical Trials of Drug Treatment for Hypertension A Review
Jeffrey A. Cutler (1989)
10.1161/01.CIR.0000068337.25994.21
Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation
Ravi Kanagala (2003)
10.1152/ajpheart.2000.279.1.H234
Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea.
Bradley G. Phillips (2000)
10.1001/jama.287.8.1003
Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.
Ramachandran S Vasan (2002)
10.1016/S0009-9236(96)90161-7
Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema.
Nancy J. Brown (1996)
10.1001/jama.284.23.3015
Longitudinal study of moderate weight change and sleep-disordered breathing.
Paul E. Peppard (2000)
10.1016/S0735-1097(01)01788-0
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat
Kim A. Eagle (2002)
10.1016/S0140-6736(00)02526-5
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study
Lennart Hansson (2000)
10.1161/01.CIR.94.3.483
Prospective study of oral contraceptives and hypertension among women in the United States.
Lisa Chasan-Taber (1996)
10.1177/002188637601200414
Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes
André L. Delbecq (1976)
10.4065/78.2.211
Two words to improve physician-patient communication: what else?
Patricia A. Barrier (2003)
10.1097/jnn.0b013e318274cc4d
A Review of the
Robert Wolpert (1985)
Drug therapy: vasodilator drugs in peripheral vascular disease.
Jay D. Coffman (1979)
Renal failure related to angiotensin-converting enzyme inhibitors.
Stephen C. Textor (1997)
10.1111/j.1600-0404.1996.tb00054.x
Leuko-araiosis and stroke: a case-control study.
Adnan A. Awada (1996)
Hearts N' Parks
MD (University of Texas Southwestern Medical School at Dallas
Norman M Kaplan
Mad as a hatter? Join our campaign for a mercury free NIH
Persons 65 Years Old and Over–Characteristics by Sex: 1980 to 2000. Statistical Abstracts of the United States
U S Census (2001)
Hypertensive crisis Hypertension: A Companion to Brenner and Recot's The Kidney
Da Calhoun (2000)
10.2337/diaclin.21.3.120
Treatment of hypertension in adults with diabetes.
Carlos Arauz-Pacheco (2003)
10.1111/j.1524-6175.2001.00449.x
Emergency room management of hypertensive urgencies and emergencies.
Donald G. Vidt (2001)
10.1016/S0140-6736(96)11445-8
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
The Gisen Group (1997)
10.1016/S0140-6736(98)08049-0
Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis
Peter von Dadelszen (2000)
10.1001/jama.289.19.2534
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Bruce M. Psaty (2003)
10.1007/978-3-642-79077-5_3
The influence of menopause on blood pressure.
Jan A Staessen (1988)
10.1212/WNL.56.12.1683
Midlife vascular risk factors and late-life mild cognitive impairment
Miia Kivipelto (2001)
10.1001/jama.282.21.2012
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.
Jeremiah Stamler (1999)
10.1161/01.HYP.29.1.8
Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
Richard H. Grimm (1997)
10.1161/circ.106.25.3143
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
Scott M Grundy (2002)
10.1161/01.STR.27.8.1274
Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.
W. T. Longstreth (1996)
10.1056/NEJMoa010273
Characteristics of patients with uncontrolled hypertension in the United States.
David J. Hyman (2001)
10.1056/NEJM199406303302603
Diuretic Therapy for Hypertension and the Risk of Primary Cardiac Arrest
David S Siscovick (1994)
10.1161/01.CIR.0000042706.47107.7A
Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea
Heinrich F. Becker (2003)
10.1161/01.CIR.0000056521.67546.AA
Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives: A Prospective Study
Kazuomi Kario (2003)
10.1016/S0161-6420(02)01931-0
The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study.
Tien Yin Wong (2003)
10.1161/01.cir.91.3.698
Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS).
Philip R. Liebson (1995)
10.1161/01.CIR.96.1.308
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study.
Stanley S. Franklin (1997)
10.1016/S1062-1458(02)00536-6
Impact of high-normal blood pressure on the risk of cardiovascular disease.
Ramachandran S Vasan (2001)
10.1056/NEJM199808203390801
Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.
Stephen S Gottlieb (1998)
10.1093/aje/153.1.72
Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.
Mauro Di Bari (2001)
Your guide to lowering high blood pressure
National Heart (2003)
Reducing risks, promoting healthy life
(2002)
Cardiovascular Therapeutics: A Companion to Braunwald’s Heart Disease
UdhoThadani (2002)
J Clin Hypertens (Greenwich)
Wm Manger (2002)
Hypertension in blacks Strong Heart Study Data Book: A Report to American Indians Communities
R Cooper (1997)
10.1378/chest.103.5.1336
Adiposity and cardiovascular risk factors in men with obstructive sleep apnea.
P D Levinson (1993)
10.1038/ki.1995.281
Renovascular disease in older patients beginning renal replacement therapy.
Richard G. Appel (1995)
MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION
teven (2000)
10.1016/S0140-6736(95)90820-X
Sleep apnoea and nocturnal angina
Karl A. Franklin (1995)
10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.0.CO;2-G
Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance.
J. P. Bastard (2000)
10.1056/NEJMoa021716
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.
Lindon M.H. Wing (2003)
10.1016/s0140-6736(00)04560-8
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
Henry J. Dargie (2001)
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
Kdoqi Disclaimer (2002)
10.1136/bmj.321.7258.412
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
Amanda I. Adler (2000)
10.1067/moe.2002.123866
A systematic review of cardiovascular effects of epinephrine on hypertensive dental patients.
James D. Bader (2002)
Cardiovascular therapeutics : a companion to Braunwald's heart disease
Thomas W. Smith (1996)
10.1053/ajkd.2002.36321
Relationship of renal function to homocysteine and lipoprotein(a) levels: the frequency of the combination of both risk factors in chronic renal impairment.
Darren S Parsons (2002)
American Academy of Physician Assistants; American Association of Occupational Health Nurses
2002-4 Reducing sodium content in the American diet
(2002)
Treatment of hypertension combined with cardiovascular disease
W G Haynes (1996)
X 162. Prevalence of Diabetes and Impaired Fasting Glucose in Adults-United States
A H Mokdad (1999)
2002– 4 Reducing sodium content in the American diet. Association News
(2002)
10.1016/0895-7061(95)00341-X
Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel.
Thomas G. Pickering (1996)
10.1016/S1062-1458(03)00290-3
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
Bertram Pitt (2003)
10.1001/archinte.1997.00440360178019
Population-based study of sleep-disordered breathing as a risk factor for hypertension.
Terry B Young (1997)
10.1016/S0002-9343(99)00425-8
The association between orthostatic hypotension and recurrent falls in nursing home residents.
Wee Lock Ooi (2000)
10.1097/00132578-200307000-00027
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
Aram V. Chobanian (2003)
10.1093/aje/154.1.50
Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study.
A B Newman (2001)
10.1161/01.STR.17.6.1090
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations.
Issam A. Awad (1986)
10.1001/archinte.160.4.481
Implications of a health lifestyle and medication analysis for improving hypertension control.
Matthew R. Weir (2000)
10.1161/01.HYP.36.5.780
Hypertension and Its Treatment in Postmenopausal Women: Baseline Data from the Women’s Health Initiative
Sylvia Wassertheil-Smoller (2000)
Angioplasty for the Treatment of Azotemia and Renovascular Hypertension in Atherosclerotic Renal Artery Disease
Thomas A. Sos (1991)
10.1161/01.HYP.37.3.869
Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives: Analysis Based on National Health and Nutrition Examination Survey (NHANES) III
Stanley S. Franklin (2001)
10.1136/bmj.317.7160.713
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
M R Stearne (1998)
10.1097/00006254-200108000-00019
Physical activity and coronary heart disease in women: is "no pain, no gain" passé?
I M Lee (2001)
10.1136/bmj.324.7330.141
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
Trialists Antithrombotic (2002)
10.1001/jama.1995.03520270033028
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
Valery T. Miller (1995)
10.7326/0003-4819-135-12-200112180-00005
Effects of Diet and Sodium Intake on Blood Pressure: Subgroup Analysis of the DASH-Sodium Trial
William M. Vollmer (2001)
10.1001/archinte.159.17.2004
The role of diastolic blood pressure when treating isolated systolic hypertension.
Grant W. Somes (1999)
10.1067/mob.2002.120080
Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia.
Alan Buchbinder (2002)
10.1097/00006324-192607000-00021
AMERICAN OPTOMETRIC ASSOCIATION
Gerda Klunder (1925)
10.1001/jama.287.3.356
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.
Earl S. Ford (2002)
10.1016/0140-6736(93)92693-N
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
T. R. Investigators (1993)
10.1007/BF03215777
Hypertension in multicultural and minority populations: Linkin communication to compliance
Joseph R. Betancourt (1999)
10.1001/archinte.161.5.685
Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE).
Lawrence J. Appel (2001)
10.1136/bmj.326.7404.1427
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
Malcolm R Law (2003)
10.1093/ajh/6.10.815
Comparison of left ventricular mass and geometry in black and white patients with essential hypertension.
Michael J. Koren (1993)
Effect of a primary care physician-focused, population-based approach to blood pressure control.
Susan K. Maue (2002)
10.1016/S0090-4295(99)80191-5
Doxazosin in benign prostatic hyperplasia: effects on blood pressure and urinary flow in normotensive and hypertensive men.
Roger S. Kirby (1995)
10.1161/01.STR.30.11.2440
Serial magnetic resonance imaging of rat brain after induction of renal hypertension.
Marc R Del Bigio (1999)
Management of posttransplant hypertension
VJ Canzanello (2003)
10.1001/archinte.163.5.525
Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.
Janice G. Douglas (2003)
National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report
Pwf Wilson (1998)
Controlled clinical trials of drug treatment for hypertension: a review. Hypertension
JA Cutler (1989)
Implications of the INTERSALT study. Hypertension
R. Stamler (1991)
Treatment of hypertension patients with ischemic heart disease Hypertension Primer: The Essentials of High Blood Pressure: Basic Science, Population Science, and Clinical Management
C Rosendorff (2003)
Cardiovascular disease enhanced dissemination and utilization centers (EDUCs) awardees. Available at: http://hin.nhlbi.nih.gov/educs/awardees.htm. Accessed November
National Heart (2003)
Understanding and 227. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report
U Department (1998)
Interpretation and evaluation of clinical guidelines Hypertension Primer: The Essentials of High Blood Pressure: Basic Science, Population Science, and Clinical Management
E Roccella (2003)
10.1161/01.CIR.100.7.706
Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy.
Kelly Chin (1999)
10.1016/S1062-1458(03)00275-7
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Henry R. Black (2003)
10.1161/01.CIR.102.21.2607
Impairment of Endothelium-Dependent Vasodilation of Resistance Vessels in Patients With Obstructive Sleep Apnea
Masahiko Kato (2000)
10.1097/00045391-200103000-00003
Cyclooxygenase-2–Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients
Andrew A Whelton (2001)
10.4135/9781412963862.n17
The American Dietetic Association
Christine Thomson (1926)



This paper is referenced by
10.1016/B978-0-323-42973-3.00009-3
9 – Office Blood Pressure Measurement
Clarence E. Grim (2018)
10.1186/s12245-018-0187-6
Elevated blood pressure and illness beliefs: a cross-sectional study of emergency department patients in Jamaica
Taneisha T Wilson (2018)
10.3233/JAD-180441
The Distribution of Urinary Alzheimer-Associated Neuronal Thread Protein and Its Association with Common Chronic Diseases in the General Population.
He Jin (2018)
10.1097/HJH.0000000000001514
A novel healthy blood pressure phenotype in the Long Life Family Study
Megan M Marron (2018)
10.1080/10641963.2016.1246564
Addition of spironolactone in patients with resistant hypertension: A meta-analysis of randomized controlled trials
Liping Liu (2017)
10.1097/HJH.0000000000001310
Angiotensin II/Angiotensin (1–7) ratio and 24-h blood pressure throughout the menstrual cycle and in women using oral contraceptives
Gina C Davis (2017)
10.1515/bjmg-2017-0002
Association of the Apolipoprotein A-I Gene Polymorphisms with Cardiovascular Disease Risk Factors and Atherogenic Indices in Patients from Assam, Northeast India
Kaustubh Bora (2017)
10.1186/s12872-020-01599-7
Multi-state analysis of hypertension and mortality: application of semi-Markov model in a longitudinal cohort study
Azra Ramezankhani (2020)
10.1152/ajprenal.00639.2017
Vascular type 1 angiotensin receptors control blood pressure by augmenting peripheral vascular resistance in female mice.
E. L. Wolf (2018)
10.4172/Neuropsychiatry.1000390
The Disparity of Angiotensinogen M235T Polymorphism in Patients with Major Depressive Disorder and Hypertension
Wei Tsung Kao (2018)
10.1161/HYPERTENSIONAHA.109.136622
Moderate exercise decreases inflammation and oxidative stress in hypertension: but what are the mechanisms?
Ana María Briones (2009)
10.1038/sj.jhh.1001762
Angiotensin receptor blockade in the challenging era of systolic hypertension
George S Stergiou (2004)
10.1016/J.PTDY.2018.03.037
2017 ACC/AHA guidelines for BP management in adult patients
Karen J. McConnell (2018)
10.1136/bmjgh-2016-000221
Prevalence of non-communicable disease risk factors in three sites across Papua New Guinea: a cross-sectional study
Patricia Rarau (2017)
10.1053/j.ajkd.2016.10.035
Food Insecurity, CKD, and Subsequent ESRD in US Adults.
Tanushree Banerjee (2017)
10.20524/aog.2016.0052
Small bowel enteropathy associated with olmesartan medoxomil treatment
Michail Galanopoulos (2017)
10.1111/iwj.12642
Comparison of five systems of classification of diabetic foot ulcers and predictive factors for amputation
Byung-Joon Jeon (2017)
10.1093/occmed/kqx033
Cardiac health and fitness of Colorado male/female firefighters.
Kaigang Li (2017)
10.1016/j.jash.2017.04.005
Relationship among age, insulin resistance, and blood pressure.
Chan-Hee Jung (2017)
10.1177/1074248416672009
Side Effects of CV Medications Following Hospitalization for ACS Are Associated With More Frequent Health-Care Contacts
Rachel J. Le (2017)
10.3390/ijerph14040451
Job Strain and Casual Blood Pressure Distribution: Looking beyond the Adjusted Mean and Taking Gender, Age, and Use of Antihypertensives into Account. Results from ELSA-Brasil
Leidjaira Lopes Juvanhol (2017)
10.1080/00207454.2016.1214131
Young ischemic stroke in Tunisia: a multicentric study
Asma Kefi (2017)
10.4102/phcfm.v8i1.1210
Vitamin D status, hypertension and body mass index in an urban black community in Mangaung, South Africa
Ronette Lategan (2016)
10.1371/journal.pone.0165036
Non-Communicable Disease Risk Factors among Employees and Their Families of a Saudi University: An Epidemiological Study
Rasmieh A Alzeidan (2016)
10.1093/ajh/hpw001
Cardiac Protective Effects of Moringa oleifera Seeds in Spontaneous Hypertensive Rats.
Joseph Iharinjaka Randriamboavonjy (2016)
10.1038/hr.2016.11
Hypertension and obstructive sleep apnea
Anping Cai (2016)
10.1155/2016/6712529
Genetic Analysis of the Atrial Natriuretic Peptide Gene Polymorphisms among Essential Hypertensive Patients in Malaysia
Nooshin Ghodsian (2016)
10.1080/09637486.2016.1186157
An observational study of sequential protein-sparing, very low-calorie ketogenic diet (Oloproteic diet) and hypocaloric Mediterranean-like diet for the treatment of obesity
Giuseppe Castaldo (2016)
10.3390/nu8070444
Potassium Intake, Bioavailability, Hypertension, and Glucose Control
Michael S. Stone (2016)
10.1016/j.jmpt.2016.04.002
Effect of Spinal Manipulation of Upper Cervical Vertebrae on Blood Pressure: Results of a Pilot Sham-Controlled Trial.
Christine Goertz (2016)
10.3386/w22306
Understanding the Improvement in Disability Free Life Expectancy in the U.S. Elderly Population
Michael E. Chernew (2016)
10.9790/0853-1510040409
Studies of the Anti Oxidant Status in Subjects With Altered Metabolism in Niger Delta Region of Nigeria
Ferdinand Chukwuma Ezeiruaku (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar